Unknown

Dataset Information

0

Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.


ABSTRACT: The authors previously identified plasma plasminogen activator inhibitor-1 (PAI-1) level as a quantitative lung injury biomarker in primary graft dysfunction (PGD). They hypothesized that plasma levels of PAI-1 used as a quantitative trait could facilitate discovery of genetic loci important in PGD pathogenesis. A two-stage cohort study was performed. In stage 1, they tested associations of loci with PAI-1 plasma level using linear modeling. Genotyping was performed using the Illumina CVD Bead Chip v2. Loci meeting a p < 5?×?10(-4) cutoff were carried forward and tested in stage 2 for association with PGD. Two hundred ninety-seven enrollees were evaluated in stage 1. Six loci, associated with PAI-1, were carried forward to stage 2 and evaluated in 728 patients. rs3168046 (Toll interacting protein [TOLLIP]) was significantly associated with PGD (p?=?0.006). The increased risk of PGD for carrying at least one copy of this variant was 11.7% (95% confidence interval 4.9-18.5%). The false-positive rate for individuals with this genotype who did not have PGD was 6.1%. Variants in the TOLLIP gene are associated with higher circulating PAI-1 plasma levels and validate for association with clinical PGD. A protein quantitative trait analysis for PGD risk prioritizes genetic variations in TOLLIP and supports a role for Toll-like receptors in PGD pathogenesis.

SUBMITTER: Cantu E 

PROVIDER: S-EPMC4767612 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.

Cantu E E   Suzuki Y Y   Diamond J M JM   Ellis J J   Tiwari J J   Beduhn B B   Nellen J R JR   Shah R R   Meyer N J NJ   Lederer D J DJ   Kawut S M SM   Palmer S M SM   Snyder L D LD   Hartwig M G MG   Lama V N VN   Bhorade S S   Crespo M M   Demissie E E   Wille K K   Orens J J   Shah P D PD   Weinacker A A   Weill D D   Wilkes D D   Roe D D   Ware L B LB   Wang F F   Feng R R   Christie J D JD  

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20151210 3


The authors previously identified plasma plasminogen activator inhibitor-1 (PAI-1) level as a quantitative lung injury biomarker in primary graft dysfunction (PGD). They hypothesized that plasma levels of PAI-1 used as a quantitative trait could facilitate discovery of genetic loci important in PGD pathogenesis. A two-stage cohort study was performed. In stage 1, they tested associations of loci with PAI-1 plasma level using linear modeling. Genotyping was performed using the Illumina CVD Bead C  ...[more]

Similar Datasets

| S-EPMC3313997 | biostudies-literature
| S-EPMC2362067 | biostudies-literature
| S-EPMC8743249 | biostudies-literature
2010-06-25 | E-GEOD-7628 | biostudies-arrayexpress
| S-EPMC7545568 | biostudies-literature
2008-03-04 | GSE7628 | GEO
| S-EPMC1224534 | biostudies-literature
| S-EPMC4282084 | biostudies-other
| S-EPMC7933020 | biostudies-literature
| S-EPMC2890984 | biostudies-literature